NewsBenzingaSutro Biopharma、第3四半期EPSは(1.90ドル)で予想(1.91ドル)を上回る、売上高は910万ドルで予想1034.2万ドルを下回る Sutro Biopharma、第3四半期EPSは(1.90ドル)で予想(1.91ドル)を上回る、売上高は910万ドルで予想1034.2万ドルを下回る Benzinga 2026.11.12 21:41 (GMT+0) Open on Benzinga Other news Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions Ledger Hardware Wallet Tampering Spreads to Dubai as Two Users Lose About $604K Nvidia Board Has No Plans to Reinstate Jensen Huang AMD completes acquisition of AI inference chip company Taalas HUYA Inc. (HUYA) Q3 2026 Earnings Call Transcript Key Overnight and Morning News (Nov 17 – Nov 18)
Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions